The latest gynaecological cancer news
On January 12, 2024, the Food and Drug Administration approved pembrolizumab with chemoradiotherapy (CRT) for patients…
A new editorial paper was published in Oncotarget’s Volume 14 on December 22, 2023, entitled, “One more step…
A new Peter Mac study using a pioneering drug has successfully controlled the growth of…
Investigators from the C.S. Mott Center for Human Growth and Development at the Wayne State…
Patients with metastatic or recurrent cervical cancer not amenable to curative surgery and/or radiotherapy have…
Actively monitoring abnormal cells (lesions) that line the cervix rather than removing them straight away…
Our DNA is not indestructible. Throughout the course of our lives, DNA can break in…
Australia is stepping up its regional leadership in the elimination of cervical cancer, with the…
A model based on artificial intelligence is able to predict the therapy outcome (measured by…
Testing for genetic biomarkers can predict which cancer patients are likely to benefit from DNA…